Skip to content
OpenCapital
Get started

Materion MTRN Life sciences — Net Sales

Other product segments

Semiconductor
$318.36M+69.2%
Aerospace and defense
$59.01M+17.9%
Industrial
$51.86M+9.6%
Energy
$46.65M+27.3%
Consumer electronics
$30.97M-37.1%
Other
$25.28M+36.3%
Automotive
$19.23M+5.3%

Similar metrics at other companies

Bio-Rad Laboratories logo
BIOLife Science — Net Sales
$228.5M0.0%
GLW
GLWLife Science Products — Net Sales
$228M0.0%
Donaldson Company logo
DCILife Sciences Segment — Net Sales
$83.5M+12.5%
Agilent Technologies logo
ALife Sciences and Diagnostics Markets — Net revenue
$732M+11.9%
Danaher logo
DHRLife Sciences — Sales
$1.74B+3.4%
AVT
AVTRBioscience & Medtech Products — Net Sales
$431.4M+1.2%

Other financials

Income statement

See full
Revenue$549.8M+30.8%
Gross profit$81.8M+7.4%
Operating income$28.2M+3.6%
Net income$19.4M+9.5%
EPS (diluted)$0.92+8.2%

Balance sheet

See full
Cash & equivalents$16.2M+3.5%
Total debt$562.4M+4.8%
Total equity$957.0M+7.8%
Total assets$1.9B+7.1%

Cash flow

See full
Operating cash flow-$4.3M-128%
CapEx$15.3M+24.1%
Free cash flow-$19.6M-716%

Valuation

See full
Market cap$5.72B+77.2%
Enterprise value$6.27B+60.2%
P/E74.8×—
P/S3×+1.1×

Profitability

See full
Gross margin16.4%-2.8pp
Operating margin5.8%—
Net margin4%—
FCF margin1.4%-1.9pp

Returns & leverage

See full
Return on equity8.3%—
Debt / equity0.6×0.0×
Current ratio3×+0.2×

Where this comes from

Reported directly by Materion in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Materion’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Materion's life sciences — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Materion's life sciences — net sales?
Materion (MTRN) reported life sciences — net sales of -$1.53M in Q1 2026.
How has Materion's life sciences — net sales changed year-over-year?
Materion's life sciences — net sales decreased by 112.6% year-over-year, from $12.14M to -$1.53M.
What is the long-term trend for Materion's life sciences — net sales?
Over 4 years (2021 to 2025), Materion's life sciences — net sales has grown at a -3.4% compound annual growth rate (CAGR), from $53.68M to $46.78M.
What does life sciences — net sales mean?
This metric represents the total revenue generated from products and services specifically tailored for the life sciences sector, including medical devices, diagnostic equipment, and biotechnology applications. It serves as a key indicator of the company's penetration into high-growth healthcare and clinical markets. Tracking this revenue stream helps investors assess the diversification of the company's material science portfolio beyond traditional industrial and electronic applications.